«Combat» readiness of Astrapharm to provide Ukrainians with a sufficient amount of antibacterial drugs
Along with a steady increase in the incidence of coronavirus disease (COVID-19), the number of associated bacterial co-infections is also increasing. Bacterial pneumonia, sepsis, or septic shock – all of these conditions require antibiotics.
The pharmaceutical company Astrapharm remains one of the main manufacturers of antibiotics in Ukraine, and it is ready to provide consumers with a sufficient amount of drugs that are needed for the effective treatment of bacterial infections.
Please note that isotropic antibiotic therapy is prescribed only by a doctor according to established clinical indications, such as the presence of pathogens according to the results of microbiological studies, intoxication, leukocytosis, neutrophilia, increased level of C-reactive protein and procalcitonin.
Uncontrolled use of antibiotics can lead to acquired drug resistance – the ability of microorganisms to survive and multiply, despite the presence of antibiotics. This situation endangers future treatment and prevention of infections caused by bacteria.
Realising its responsibility for the health of Ukrainians, Astrapharm continuously produces high-quality and affordable antibacterial drugs.
Astrapharm – the art of helping people!